HomeCancerLeukemia

Leukemia

Leukemia

SELLAS Pronounces U.S. FDA Uncommon Pediatric Illness Designation (RPDD) Granted to SLS009 for the Therapy of Pediatric Acute Myeloid Leukemia

Editor -
- Acute Myeloid Leukemia (AML) is the Second Most Widespread Hematological Malignancy in Youngsters Usually Related to Poorer Prognosis In comparison with Different...
Leukemia

SELLAS Declares U.S. FDA Uncommon Pediatric Illness Designation (RPDD) Granted to SLS009 for the Remedy of Pediatric Acute Myeloid Leukemia

Editor -
...
Leukemia

SELLAS Broadcasts U.S. FDA Uncommon Pediatric Illness

Editor -
- Acute Myeloid Leukemia (AML) is the Second Most Frequent Hematological Malignancy in Kids Usually Related to Poorer Prognosis In comparison with Different...
Leukemia

FDA Locations Partial Medical Maintain on Part 1 Trial of Seclidemstat Plus Azacitidine in MDS/CMML

Editor -
The FDA has positioned a partial scientific maintain on a section 1 trial (NCT04734990) evaluating seclidemstat (SP-2577) together with azacitidine (Vidaza) for the...
Leukemia

‘Rally for Ryan’: Household organizes profit for Champaign man with leukemia | Native Information

Editor -
1...293031...80Page 30 of 80

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.